Literature DB >> 12853213

Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer.

Marc Tischkowitz, Ros Eeles.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12853213     DOI: 10.1016/S0140-6736(03)13823-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Translational and clinical implications of the genetic landscape of prostate cancer.

Authors:  Daniel E Spratt; Zachary S Zumsteg; Felix Y Feng; Scott A Tomlins
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

Review 2.  The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment.

Authors:  Daniel H Hovelson; Scott A Tomlins
Journal:  Cancer J       Date:  2016 Sep/Oct       Impact factor: 3.360

3.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

4.  The clinical genetics of prostate cancer.

Authors:  Sashi Kommu; Stephen Edwards; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.